Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally

NCT02346487 is registered in ClinicalTrials.gov with Drugs for Neglected Diseases as lead sponsor.

NCT NCT02346487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02346487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally
Lead sponsor
Drugs for Neglected Diseases
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2015
Completion date
May 14, 2019
Enrollment
1,003 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hiv